Cart
sales@molnova.com
Piboserod
CAS No. 152811-62-6
Piboserod( SB-207266 )
Catalog No. M17331 CAS No. 152811-62-6
Piboserod (SB 207266) is a selective 5-HT(4) receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 123 | In Stock |
|
| 2MG | 46 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 121 | In Stock |
|
| 25MG | 233 | In Stock |
|
| 50MG | 416 | In Stock |
|
| 100MG | 601 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1237 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePiboserod
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiboserod (SB 207266) is a selective 5-HT(4) receptor antagonist.
-
DescriptionPiboserod (SB 207266) is a selective 5-HT(4) receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsSB-207266
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
Recptor5-HT4
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number152811-62-6
-
Formula Weight369.51
-
Molecular FormulaC22H31N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 36 mg/mL. 97.43 mM
-
SMILESCCCCN1CCC(CC1)CNC(=O)c1c2n(CCCO2)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kjekshus JK, et al. Eur J Heart Fail. 2009 Aug;11(8):771-8.2. Nirogi R, et al. J Pharm Pharmacol. 2013 May;65(5):704-12.
molnova catalog
related products
-
ML-60218
ML-60218 (ML60218)?is a broad-spectrum, small molecule inhibitor of RNA polymerase (Pol) III with IC50 of 32 and 27 uM for Saccharomyces cerevisiae and human, respectively.
-
SMN-C2
SMN-C2 is a selective regulator of SMN2 gene splicing, a risdiplam analogue, a selective RNA-binding ligand that regulates pre-mRNA splicing and acts by binding to SMN2 pre-mRNA.
-
Tallimustine HCl
Tallimustine HCl is a DNA inhibitor, an AT-specific alkylated antitumor derivative of diamycin.Tallimustine HCl can be used in severe combined immunodeficiency mouse models of adult myelogenous leukemia, which can be used for the treatment of leukemia.
